NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP)

Kyle M. Blackburn, Elena I. Ivleva, Robert A. Weir, Mindy Kim, Steven C. Hopkins, Matthew E. Hudgens-Haney, Sarah K. Keedy, Elliot S. Gershon, John A. Sweeney, Matcheri S. Keshavan, Godfrey D. Pearlson, Brett A. Clementz, Carol A. Tamminga, Steven Vernino

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)318-320
Number of pages3
JournalSchizophrenia Research
Volume218
DOIs
StatePublished - Apr 2020

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Blackburn, K. M., Ivleva, E. I., Weir, R. A., Kim, M., Hopkins, S. C., Hudgens-Haney, M. E., Keedy, S. K., Gershon, E. S., Sweeney, J. A., Keshavan, M. S., Pearlson, G. D., Clementz, B. A., Tamminga, C. A., & Vernino, S. (2020). NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP). Schizophrenia Research, 218, 318-320. https://doi.org/10.1016/j.schres.2020.01.004